Member Type: Diagnostic Companies
Luminex Corporation develops innovative scientific technologies, instruments and assays that are used across life science research and clinical diagnostics markets. Our foundational xMAP multiplexing technology allows scientists and researchers to conduct multiple, simultaneous tests on a single sample, making research and healthcare faster, more accurate, efficient and affordable. The flexible xMAP platform can be used to analyze both nucleic acids and proteins, and offers an instrument portfolio that can multiplex 1 to 500 analytes on a single sample. These multiplexing solutions are utilized worldwide in a variety of applications including pharmacogenomics, molecular infectious disease, respiratory viral testing, genetic disease, transplant diagnostics, drug development, oncology research and bioterror surveillance.